A variety of treatment options exist for rheumatoid arthritis. Despite their wide availability, some patients remain untreated. How can biologics for rheumatoid arthritis help people with unmet needs? Image source: Flickr Commons The development of effective biologic drugs has brought relief to many people with chronic conditions—especially that of rheumatoid […]
Scientists have discovered a cure for MS that works in a small portion of the affected population and promises to be a tool for learning how to cure the rest. Image Source: Flickr User: SFU – University Communications A few weeks ago, the CBC (Canadian Broadcasting Corporation) broke the news […]
Viruses have played con-man to tissues and immune systems for a long time. By harnessing these capabilities, researchers are attempting to create nanoreactors and better therapeutic vehicles. Image Source: Wikimedia Commons User Splette Viruses are a non-living anomaly in the microscopic world; they make a living out of hijacking a […]
Recent developments in biologic therapies may bring an end to the off-label use of chemotherapy and other salvage therapies in hemophagocytic lymphohistiocytosis. Image Source: Wikimedia Commons user: Bill Branson Cancer may be the darling of the research world, but there are other, rarer diseases that require just as much care […]
As life science firms look for patient populations to help by designing novel biotherapeutics, they will need to ensure their research efforts allow for efficient drug discovery and development.
Companies can prepare to compete with biosimilars by adopting a simple, yet effective, strategy: innovation. By developing drugs that improve upon earlier iterations, companies can continue to protect their market advantage from lower-cost generic versions.
There is a growing need for more efficacious retinal degenerative disease treatment as the population ages and there is mounting exposure to common causes.
There is a growing body of research highlighting the unique properties of cancer stem cells and scientists can use this information to design biologic drugs that exploit CSC properties in order to provide more effective treatment strategies for cancer.
The FDA approved an active hemostatic agent called Raplixa for use in surgery in April 2015. Hemostatic agents may be considered either mechanical or active. Mechanical agents prevent bleeding by forming a mechanical barrier, whereas active hemostats contain active biological materials.
Cancer cells are often present in the body without ever turning into full-blown cancer. In theory, the body has natural mechanisms which seek out and destroy cancer cells. It truly becomes “cancer” when cancer cells are able to evade immune detection and destruction, and set up camp within the body. […]